{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:06:11Z","timestamp":1790867171321,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Specific death due to DR-TB has significantly contributed to tuberculosis (TB) mortality and overall global deaths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>This study examines the predictors of mortality among DR-TB patients in Kaduna State, Nigeria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subject and Method:<\/jats:title>\n                    <jats:p>This was a retrospective longitudinal study of DR-TB mortality carried out among 370 DR-TB patients from the 23 LGAs in Kaduna State. It involves a retrospective review of the MDR-TB records of the patients over a period of 10 years (2012\u20132021). Demographic and clinical data of all DR-TB patients enrolled in Kaduna State, Nigeria, between April 1, 2012, and March 31, 2021, were used. Survival analysis was performed with SPSS version 25, using Kaplan\u2013Meier and Cox proportional hazard regression modeling, at 5% significance level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The majority of the patients, 255 (68.9%), were below the age of 40 years, while 53 (14.3%) of the patients died within the study period. Most deaths 26 (49.1%) were associated with HIV co-infection and the disease severity. Results for the Cox proportional model show that there was a significantly lower risk of death when a patient had MDR-TB compared to pre-XDR-TB (adjusted hazard ratio, AHR = 0.34, 95% CI = 0.16\u20130.72,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04). Both models show that age, sex, residence, or year of treatment had no significant association with survival or death.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>HIV co-infection and DRTB with progression to more resistant and difficult-to-treat strains contributed to higher deaths. There is a need for concerted efforts from all DR-TB stakeholders to control the disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_734_22","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T06:01:58Z","timestamp":1689314518000},"page":"825-831","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Predictors of Mortality among Drug-Resistant Tuberculosis Patients in Kaduna State, Nigeria"],"prefix":"10.4103","volume":"26","author":[{"given":"AM","family":"Oyefabi","sequence":"first","affiliation":[{"name":"Department of Community Medicine, College of Medicine, Zaria, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CI","family":"Tobin West","sequence":"additional","affiliation":[{"name":"College of Health Sciences and School of Public Health, University of Port Harcourt, Cross River State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ameh","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, University of Calabar, Cross River State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EN","family":"Jiya","sequence":"additional","affiliation":[{"name":"National Tuberculosis and Leprosy Training Centre, Zaria, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sadiq","sequence":"additional","affiliation":[{"name":"Tuberculosis Unit, Kaduna State Ministry of Health, Kaduna State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Dauda","sequence":"additional","affiliation":[{"name":"World Health Organization, Niger State Field Office, Minna, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Onoh","sequence":"additional","affiliation":[{"name":"Communicable and Non Communicable Diseases Cluster, World Health Organization, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"R1-20240907","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/hpm.2929","article-title":"Support and unmet needs of patients undergoing multidrug-resistant tuberculosis (MDR-TB) treatment in southern Nigeria","volume":"35","author":"Oshi","year":"2020","journal-title":"Int J Health Plann Manage"},{"key":"R2-20240907","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12916-017-1001-7","article-title":"Multidrug-resistant tuberculosis treatment adherence in migrants:A systematic review and meta-analysis","volume":"16","author":"Nellums","year":"2018","journal-title":"BMC Med"},{"key":"R3-20240907","first-page":"530","article-title":"Multi drug resistant tuberculosis an emerging concern a study at tertiary health center in Nigeria","volume":"7","author":"Dunga","year":"2018","journal-title":"EC Pulmonol Respir Med"},{"key":"R4-20240907","doi-asserted-by":"crossref","first-page":"e022948","DOI":"10.1136\/bmjopen-2018-022948","article-title":"Knowledge and practice of health workers about control and prevention of multidrug-resistant tuberculosis in referral hospitals, Ethiopia:A cross-sectional study","volume":"9","author":"Alene","year":"2019","journal-title":"BMJ Open"},{"key":"R5-20240907","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ijid.2021.06.022","article-title":"Situational analysis of 10 countries with a high burden of drug-resistant tuberculosis 2 years post-UNHLM declaration:Progress and setbacks in a changing landscape","volume":"108","author":"Monedero-Recuero","year":"2021","journal-title":"Int J Infect Dis"},{"key":"R6-20240907","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12879-020-05031-5","article-title":"Molecular epidemiology of drug resistant Mycobacterium tuberculosis in Africa:A systematic review","volume":"20","author":"Chisompola","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R7-20240907","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3201\/eid2411.180769","article-title":"Outbreak of tuberculosis and multidrug-resistant tuberculosis, Mbuji-Mayi Central Prison, Democratic Republic of the Congo","volume":"24","author":"Kayomo","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"R8-20240907","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/ijpvm.IJPVM_298_17","article-title":"Factors associated with the development of secondary multidrug-resistant tuberculosis","volume":"10","author":"Sharma","year":"2019","journal-title":"Int J Prev Med"},{"key":"R9-20240907","doi-asserted-by":"crossref","first-page":"e0197737","DOI":"10.1371\/journal.pone.0197737","article-title":"Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia","volume":"13","author":"Mesfin","year":"2018","journal-title":"PLoS One"},{"key":"R10-20240907","doi-asserted-by":"crossref","first-page":"e0229040","DOI":"10.1371\/journal.pone.0229040","article-title":"The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia","volume":"15","author":"Shibabaw","year":"2020","journal-title":"PloS One"},{"key":"R11-20240907","doi-asserted-by":"crossref","first-page":"e0202469","DOI":"10.1371\/journal.pone.0202469","article-title":"Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013","volume":"13","author":"Chingonzoh","year":"2018","journal-title":"PLoS One"},{"issue":"(Suppl 1)","key":"R12-20240907","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ijid.2021.02.107","article-title":"Global Tuberculosis Report 2020\u2013Reflections on the Global TB burden, treatment and prevention efforts","volume":"113","author":"Chakaya","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"(Suppl 1)","key":"R13-20240907","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.ijid.2021.02.067","article-title":"Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic","volume":"113","author":"Tiberi","year":"2021","journal-title":"Int J Infect Dis"},{"key":"R14-20240907","doi-asserted-by":"crossref","first-page":"e0225165","DOI":"10.1371\/journal.pone.0225165","article-title":"Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria","volume":"14","author":"Bajehson","year":"2019","journal-title":"PloS One"},{"key":"R15-20240907","doi-asserted-by":"crossref","first-page":"e94393","DOI":"10.1371\/journal.pone.0094393","article-title":"Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients:Results from a nationwide cohort in Nigeria","volume":"9","author":"Oladimeji","year":"2014","journal-title":"PLoS One"},{"key":"R16-20240907","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1038\/s41598-018-23344-z","article-title":"Comorbidities and treatment outcomes in multidrug resistant tuberculosis:Systematic review and meta-analysis","volume":"8","author":"Samuels","year":"2018","journal-title":"Sci Rep"},{"key":"R17-20240907","doi-asserted-by":"crossref","first-page":"e0253848","DOI":"10.1371\/journal.pone.0253848","article-title":"Predictors of mortality in patients with drug-resistant tuberculosis:A systematic review and meta-analysis","volume":"16","author":"Alemu","year":"2021","journal-title":"PloS One"},{"key":"R18-20240907","doi-asserted-by":"crossref","first-page":"e0193903","DOI":"10.1371\/journal.pone.0193903","article-title":"Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007\u20132011):Evidence leading to policy enhancement","volume":"13","author":"Parmar","year":"2018","journal-title":"PLoS One"},{"key":"R19-20240907","doi-asserted-by":"crossref","first-page":"e21023","DOI":"10.1097\/MD.0000000000021023","article-title":"Household financial burden among multidrug-resistant tuberculosis patients in Guizhou province, China:A cross-sectional study","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R20-20240907","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S2214-109X(20)30518-0","article-title":"Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE):A prospective cohort study","volume":"9","author":"Duvignaud","year":"2021","journal-title":"Lancet Glob Health"},{"key":"R21-20240907","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S1473-3099(19)30294-4","article-title":"Outbreak of human monkeypox in Nigeria in 2017\u201318:A clinical and epidemiological report","volume":"19","author":"Yinka-Ogunleye","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R22-20240907","doi-asserted-by":"crossref","first-page":"e044079","DOI":"10.1136\/bmjopen-2020-044079","article-title":"Patient characteristics associated with COVID-19 positivity and fatality in Nigeria:Retrospective cohort study","volume":"10","author":"Elimian","year":"2020","journal-title":"BMJ Open"},{"key":"R23-20240907","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12879-017-2249-4","article-title":"High mortality among tuberculosis patients on treatment in Nigeria:A retrospective cohort study","volume":"17","author":"Adamu","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R24-20240907","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1186\/s12879-019-4317-4","article-title":"Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa:A systematic review and meta-analysis","volume":"19","author":"Chem","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"(Suppl 1)","key":"R25-20240907","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1086\/518665","article-title":"HIV infection and multidrug-resistant tuberculosis\u2014the perfect storm","volume":"196","author":"Wells","year":"2007","journal-title":"J Infect Dis"},{"key":"R26-20240907","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1016\/S2666-5247(21)00044-6","article-title":"Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing:A multicenter cohort study","volume":"2","author":"Z\u00fcrcher","year":"2021","journal-title":"The Lancet Microbe"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_734_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:14:17Z","timestamp":1787760857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_734_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_734_22","relation":{},"ISSN":["1119-3077","2229-7731"],"issn-type":[{"value":"1119-3077","type":"print"},{"value":"2229-7731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"2022-10-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}